Patent · US Expired

Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria

US5198419A · kind A · utility

24Cited by

5References

20Claims

0Family size

Assignee

Immuno Japan Inc. · JP

Inventors

Kunio Ando · Warabi, JP
Sachiko Goto · Amagasaki, JP

Key dates

Filing date	Oct 4, 1991
Grant date	Mar 30, 1993
Priority date	—
Expiry date	Oct 4, 2011

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/832
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Lactoferrin can be used to increase the efficacy of beta-lactam antibiotics. There is a potentiating effect when lactoferrin is administered either simultaneous with or shortly before or after the administration of beta-lactam antibiotics. The dosage of lactoferrin administered is usually 0.5-100 mg/kg and preferably 1-10 mg/kg.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.